1. Bioanalytical approaches for characterizing catabolism of antibody–drug conjugates. (July 2015) Authors: Saad, Ola M; Shen, Ben-Quan; Xu, Keyang; Khojasteh, S Cyrus; Girish, Sandhya; Kaur, Surinder Journal: Bioanalysis Issue: Volume 7:Number 13(2015) Page Start: 1583 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Bioanalytical approaches for characterizing catabolism of antibody–drug conjugates. (July 2015) Authors: Saad, Ola M; Shen, Ben-Quan; Xu, Keyang; Khojasteh, S Cyrus; Girish, Sandhya; Kaur, Surinder Journal: Bioanalysis Issue: Volume 7:Number 13(2015) Page Start: 1583 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Clinical pharmacology of vc-MMAE antibody–drug conjugates in cancer patients: learning from eight first-in-human Phase 1 studies. Issue 1 (1st January 2020) Authors: Li, Chunze; Zhang, Cindy; Li, Zao; Samineni, Divya; Lu, Dan; Wang, Bei; Chen, Shang-Chiung; Zhang, Rong; Agarwal, Priya; Fine, Bernard M.; Girish, Sandhya Journal: MAbs Issue: Volume 12:Issue 1(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Confounding factors in exposure–response analyses and mitigation strategies for monoclonal antibodies in oncology. Issue 6 (7th December 2020) Authors: Kawakatsu, Sonoko; Bruno, René; Kågedal, Matts; Li, Chunze; Girish, Sandhya; Joshi, Amita; Wu, Benjamin Journal: British journal of clinical pharmacology Issue: Volume 87:Issue 6(2021) Page Start: 2493 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Effect of Hepatic Impairment on Cobimetinib Pharmacokinetics: The Complex Interplay Between Physiological Changes and Drug Characteristics. Issue 2 (21st July 2020) Authors: Cheeti, Sravanthi; Deng, Yuzhong; Chang, Ilsung; Georgescu, Isabela; Templeton, Ian; Choong, Nicholas; Cheung, Kit Wun Kathy; Girish, Sandhya; Musib, Luna Journal: Clinical pharmacology in drug development Issue: Volume 10:Issue 2(2021) Page Start: 144 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Effects of Trastuzumab Emtansine (T‐DM1) on QT Interval and Safety of Pertuzumab Plus T‐DM1 in Patients With Previously Treated Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer. Issue 1 (26th February 2013) Authors: Gupta, Manish; Wang, Bei; Carrothers, Timothy J.; LoRusso, Patricia M.; Chu, Yu‐Waye; Shih, Ted; Loecke, David; Joshi, Amita; Saad, Ola; Yi, Joo‐Hee; Girish, Sandhya Journal: Clinical pharmacology in drug development Issue: Volume 2:Issue 1(2013:Jan.) Page Start: 11 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Evaluation of atezolizumab immunogenicity: Clinical pharmacology (part 1). Issue 1 (25th August 2021) Authors: Wu, Benjamin; Sternheim, Nitzan; Agarwal, Priya; Suchomel, Julia; Vadhavkar, Shweta; Bruno, Rene; Ballinger, Marcus; Bernaards, Coen A.; Chan, Phyllis; Ruppel, Jane; Jin, Jin; Girish, Sandhya; Joshi, Amita; Quarmby, Valerie Journal: Clinical and translational science Issue: Volume 15:Issue 1(2022) Page Start: 130 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Evolution of preclinical characterization and insights into clinical pharmacology of checkpoint inhibitors approved for cancer immunotherapy. Issue 8 (7th June 2022) Authors: Kasichayanula, Sreeneeranj; Mandlekar, Sandhya; Shivva, Vittal; Patel, Maulik; Girish, Sandhya Journal: Clinical and translational science Issue: Volume 15:Issue 8(2022) Page Start: 1818 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Exposure-safety and exposure-efficacy analyses of polatuzumab vedotin in patients with relapsed or refractory diffuse large B-cell lymphoma. Issue 12 (14th October 2020) Authors: Lu, Tong; Gibiansky, Leonid; Li, Xiaobin; Li, Chunze; Shi, Rong; Agarwal, Priya; Hirata, Jamie; Miles, Dale; Chanu, Pascal; Girish, Sandhya; Jin, Jin Yan; Lu, Dan Journal: Leukemia & lymphoma Issue: Volume 61:Issue 12(2020) Page Start: 2905 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Exposure–response analysis of venetoclax in combination with rituximab in patients with relapsed or refractory chronic lymphocytic leukemia: pooled results from a phase 1b study and the phase 3 MURANO study. Issue 1 (2nd January 2020) Authors: Deng, Rong; Gibiansky, Leonid; Lu, Tong; Li, Xiaobin; Lu, Dan; Li, Chunze; Girish, Sandhya; Wang, Jue; Boyer, Michelle; Shankar, Noopur; Humphrey, Kathryn; Freise, Kevin J.; Salem, Ahmed Hamed; Seymour, John F.; Kater, Arnon P.; Miles, Dale Journal: Leukemia & lymphoma Issue: Volume 61:Issue 1(2020) Page Start: 56 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗